Yahoo Web Search

Simply Wall St. via Yahoo

Bio-Techne Third Quarter 2024 Earnings: Beats Expectations

5 hours ago

ETF DAILY NEWS

Wedbush Comments on Gossamer Bio, Inc.’s Q2 2024 Earnings (NASDAQ:GOSS)

Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) – Wedbush lifted their Q2 2024 EPS estimates for Gossamer Bio in a research report issued on Monday, May 6th. Wedbush analyst L. Chico now anticipates ...

7 hours ago

Zacks via Yahoo

Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down

23 hours ago

Clinical Trials Arena via Yahoo

Regenex Bio eyes FDA meeting to confirm pivotal DMD trial

5 hours ago

GenomeWeb News

Bio-Rad Laboratories Maintains Full-Year Guide Despite Life Science Q1 Revenue Decline of 25 Percent

This story has been updated to include additional information about Bio-Rad's Droplet Digital PCR initiatives. NEW YORK – Executives at Bio-Rad Laboratories have maintained the firm's full-year ...

1 day ago

Investing.com

Earnings call: Bio-Rad sees decline in Q1 sales but maintains full-year outlook By Investing.com

1 day ago

Zacks via Yahoo

Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates

2 days ago

GuruFocus.com via Yahoo

2seventy bio Inc (TSVT) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and ...

Release Date: May 08, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points 2seventy bio Inc (NASDAQ:TSVT) successfully completed ...

8 hours ago

Fortune via Yahoo

The finance chief of this biotech company is a Harvard-trained neuroscientist who says ‘the modern day CFO needs to speak the language of the team’

5 hours ago

WFRV 5 Green Bay

Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ rehabilitation asset

By rehabilitating donor organs deemed unfit for transplant, the xenogeneic cross-circulation platform holds potential to eliminate transplant waitlist mortality. NEW YORK, May 8, 2024 /PRNewswire ...

1 day ago